To further investigate whether the elevation of GRB2 was required for DDX42‐mediated cell proliferation, radiation, and sorafenib resistance in HCC, we downregulated the protein expression of GRB2 in DDX42 overexpression cell lines. The gene discussed is GRB2; the disease is hepatocellular carcinoma.